fill

IL-17IL-17

Back to Disease
listimg

March 2025

Ixekizumab vs. Guselkumab in Plaque Psoriasis (12-Week Trial Results)

Journal
listimg

January 2025

Efficacy & Safety of Ixekizumab ± Methotrexate in PsA (52-Week SPIRIT-H2H)

Journal
listimg

June 2025

Can You Recapture Response to IL-17i Therapy After Interruption or Discontinuation in Therapy?

Faq
listimg

December 2024

What Is the Efficacy of Ixekizumab Across the GRAPPA and EULAR Domains?

Medication
listimg

April 2025

Are IL-17 Inhibitors Efficacious in Treating the Nail-DIP Complex in PsA?

Faq
listimg

October 2024

What Is the Safety Profile of Ixekizumab in PsA and axSpa?

Medication
listimg

February 2025

How Do You Explain The Timing of Ixekizumab's Clinical Efficacy to Patients?

Faq
listimg

September 2024

Describe The Mechanism of Action of Ixekizumab

Medication
listimg

September 2024

Provide Immunologic Rationale For IL17-Directed Therapy in PsA, AS, and nr-axSpA

Faq
listimg

August 2024

Describe the IL17-Induced Inflammatory Cascade

Faq
sectionimg
dotsimg

Download the app and start using it now.

appstore Download on the App Store playstore GET IT ON Google Play